Nicholas Pavlidis - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Nicholas Pavlidis's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayNicholas Pavlidis
Verified
Editor, Cancer Treatment Reviews
Beats
Adventure Sports, Preventive Health Human Interest Stories,Inclusion in Outdoors Fitness, Social Issues Outdoor Education
Haven't done any film/tv or music coverage
Content
Predicting tumour origin with cytology-based deep learning: hype or hope? - Nature Reviews Clinical Oncology
By Nicholas Pavlidis| Nature Verified The majority of patients with cancers of unknown primary have unfavourable outcomes when they receive empirical chemotherapy. The shift towards using precision medicine-based treatment strategies involves two options: tissue-agnostic or site-specific approaches. Here, we reflect on how cytology-based deep learning tools can be leveraged in these approaches
Synchronous multiple primary cancers involving rectal cancer and pelvic classical hodgkin lymphoma: the first case report
By Hubei Univeristy, Rakesh Kapoor, Alessandro Boscarelli, Nicholas Pavlidis| Frontiers@ IntroductionThe incidence of multiple primary cancers (MPC) has shown an upward trend in the general population (1), accounting for approximately 1-16% of all cancer cases (2, 3). The etiology of MPC was found to be multifactorial, involving factors, such as genetic predisposition, environmental exposures, and lifestyle choices. The presence of MPC complicates the diagnostic process, treatment plan formulation, and prognosis assessment, and no unified standard was established
Company Info
Cancer Treatment Reviews
United States